Fonte: BMC Microbiology. Unidades: FCF, ICB
Assuntos: PEPTÍDEOS, CANDIDÍASE
ABNT
ROSSI, Diego et al. Therapeutic use of a cationic antimicrobial peptide from the spider Acanthoscurria gomesiana in the control of experimental candidiasis. BMC Microbiology, v. 12, p. 1-9, 2012Tradução . . Disponível em: https://doi.org/10.1186/1471-2180-12-28. Acesso em: 12 nov. 2024.APA
Rossi, D., Muñoz, J. E., Carvalho, D. D., Belmonte, R., Faintuch, B. L., Borelli, P., et al. (2012). Therapeutic use of a cationic antimicrobial peptide from the spider Acanthoscurria gomesiana in the control of experimental candidiasis. BMC Microbiology, 12, 1-9. doi:10.1186/1471-2180-12-28NLM
Rossi D, Muñoz JE, Carvalho DD, Belmonte R, Faintuch BL, Borelli P, Miranda A, Taborda CP, Daffre S. Therapeutic use of a cationic antimicrobial peptide from the spider Acanthoscurria gomesiana in the control of experimental candidiasis [Internet]. BMC Microbiology. 2012 ; 12 1-9.[citado 2024 nov. 12 ] Available from: https://doi.org/10.1186/1471-2180-12-28Vancouver
Rossi D, Muñoz JE, Carvalho DD, Belmonte R, Faintuch BL, Borelli P, Miranda A, Taborda CP, Daffre S. Therapeutic use of a cationic antimicrobial peptide from the spider Acanthoscurria gomesiana in the control of experimental candidiasis [Internet]. BMC Microbiology. 2012 ; 12 1-9.[citado 2024 nov. 12 ] Available from: https://doi.org/10.1186/1471-2180-12-28